Improving cancer treatment with cyclotron produced radionuclides. Progress report, February 1987--September 1989

Larson, S M

doi:10.2172/10122900

Title: Improving cancer treatment with cyclotron produced radionuclides. Progress report, February 1987--September 1989

Full Record
Other Related Research

Abstract

This report is divided into six sections, each section dealing with a separate aspect of the program. The six sections are entitled (1) In Vivo Measurement of Amino Acid Transport and Protein Synthesis, (2) Angiogenesis in Human Gliomas: Correlations with Blood Flow and Transport of C-11 AIB, (3) Use of F-18 Fluoropyrimidines for Design and Evaluation of Regional and Systemic Chemotherapeutic Strategies in Human Adenocarcinomas of the Gastrointestinal Tract, (4) Enzymatic Synthesis of Metabolites Labeled with N-13 or C-11, (5) Synthesis of Amino Acids Labeled with C-11, and (6) Instrumentation: Cyclotron and Imaging Systems.

Authors:: Larson, S M

Publication Date:: Sun Dec 31 00:00:00 EST 1989

Research Org.:: Sloan-Kettering Inst. for Cancer Research, New York, NY (United States)

Sponsoring Org.:: USDOE, Washington, DC (United States)

OSTI Identifier:: 10122900

Report Number(s):: DOE/ER/60407-T3
ON: DE93007142

DOE Contract Number:: FG02-86ER60407

Resource Type:: Technical Report

Resource Relation:: Other Information: PBD: 1989

Country of Publication:: United States

Language:: English

Subject:: 62 RADIOLOGY AND NUCLEAR MEDICINE; 38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY; CARBON 11; THERAPEUTIC USES; NITROGEN 13; PROGRESS REPORT; GLIOMAS; RADIOPHARMACEUTICALS; AMINO ACIDS; DOGS; MUSCLES; LIVER; FLUORINE 18; RESEARCH PROGRAMS; 550604; 400703; UNSEALED RADIONUCLIDES IN THERAPY; RADIOISOTOPE PRODUCTION

Citation Formats


                    Larson, S M. Improving cancer treatment with cyclotron produced radionuclides. Progress report, February 1987--September 1989.  United States: N. p., 1989. 
        Web.  doi:10.2172/10122900.

Copy to clipboard


                    Larson, S M. Improving cancer treatment with cyclotron produced radionuclides. Progress report, February 1987--September 1989.  United States.  https://doi.org/10.2172/10122900

Copy to clipboard


                    Larson, S M. 1989.  
        "Improving cancer treatment with cyclotron produced radionuclides. Progress report, February 1987--September 1989".  United States.  https://doi.org/10.2172/10122900.  https://www.osti.gov/servlets/purl/10122900.

Copy to clipboard


                    
@article{osti_10122900,

  title        = {Improving cancer treatment with cyclotron produced radionuclides. Progress report, February 1987--September 1989},

  author       = {Larson, S M},

  abstractNote = {This report is divided into six sections, each section dealing with a separate aspect of the program. The six sections are entitled (1) In Vivo Measurement of Amino Acid Transport and Protein Synthesis, (2) Angiogenesis in Human Gliomas: Correlations with Blood Flow and Transport of C-11 AIB, (3) Use of F-18 Fluoropyrimidines for Design and Evaluation of Regional and Systemic Chemotherapeutic Strategies in Human Adenocarcinomas of the Gastrointestinal Tract, (4) Enzymatic Synthesis of Metabolites Labeled with N-13 or C-11, (5) Synthesis of Amino Acids Labeled with C-11, and (6) Instrumentation: Cyclotron and Imaging Systems.},

  doi          = {10.2172/10122900},

  url          = {https://www.osti.gov/biblio/10122900},
  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {Sun Dec 31 00:00:00 EST 1989},

  month        = {Sun Dec 31 00:00:00 EST 1989}

}

Copy to clipboard

Technical Report:

View Technical Report (2.70 MB)

https://doi.org/10.2172/10122900

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Biomedical research with cyclotron produced radionuclides: Progress report, February 1, 1987-September 30, 1987

Technical Report Laughlin, J; Bading, J; Balis, M; ...

The long-term objectives of the program are to develop minimally invasive methods for in vivo measurement of specific physiologic and metabolic parameters, and with those methods contribute to the understanding of the pathophysiology of cancer, and improved management of cancer patients. The specific aims of the work described in this report are the development of methodology for measuring regional amino acid transport, metabolism and protein incorporation in tumors, and non-malignant tissues using C-11 and N-13 labeled amino acids; the use of F-18 labeled fluoropyrimidines as imaging agents to aid the design and evaluation of regional and systemic chemotherapeutic strategies inmore »« less
Biomedical research with cyclotron produced radionuclides. Progress report, August 1, 1983-July 31, 1984

Technical Report Laughlin, J; Benua, R; Gelbard, A; ...

Progress is reported in the following areas: (1) preliminary evaluation of tumor localization of N-13 labeled L-amino acids; (2) evaluation of N-13 labeled amino acids and ammonia for physiological studies in patients undergoing chemotherapy for colorectal hepatic metastases; (3) evaluation of C-11 labeled alpha-aminoisobutyric acid (AIB) in patients with prostate cancer; (4) biological studies with N-13 labeled metabolites; (5) amino acid transport studies with synthetic C-11 labeled amino acids; (6) development of an imaging technique for measurement of regional perfusion; (7) carbon-11 labeled thymidine for tumor imaging and metabolic studies; (8) enzymatic synthesis of metabolites labeled with N-13 and C-11;more »« less
Biomedical research with cyclotron produced radionuclides. Progress report, February 1, 1981-December 31, 1981

Technical Report Laughlin, J.

Progress is reported in the following areas: evaluation of chemotherapeutic regimens in solid tumors using /sup 13/N-labelled amino acids; organ imaging with /sup 13/N-labelled L-amino acids; imaging with /sup 111/In-labelled-autologous platelets; synthesis and biological studies of /sup 111/In-labelled ammonia and L-amino acids; synthesis and evaluation for pancreatic imaging of /sup 11/C-labelled amino acides; radioisotope monitoring of myocardiol function; synthesis of /sup 11/C-labelled precursor compounds; reduction of radiation exposure through automation and remote control; development of an anhydrous /sup 18/F target; evaluation of radiolabelled 5-fluorouracils for scintigraphy; and methods of data analysis, modeling, and unproving instrumentation for positron-emission tomography. (EDB)
https://doi.org/10.2172/5639374

Full Text Available
Biomedical research with cyclotron-produced radionuclides. Progress report, August 1, 1982-July 31, 1983

Technical Report Laughlin, J; Benua, R; Gelbard, A; ...

The contents include brief descriptions of the following research programs: an evaluation of chemotherapeutic regimens in solid tumors with N-13 labelled L-amino acids, studies of N-13 L-amino acid metabolism in vivo, and evaluation of N-13 labelled amino acids and ammonia for physiological studies of patients undergoing chemotherapy; biological studies with N-13 and C-11 labelled amino acids and ammonia; synthesis and development of N-13 and, C-11 labelled compounds; data analysis, modelling and instrumentation; and radionuclide production. (ACR)
Synthesis of C-11-{beta}-aminoisobutyric acid (C-11-{beta}-AlB): A major in vivo catabolite of [methyl-C-11]thymidine

Journal Article Alauddin, M; Conti, P; Fissekis, J - Journal of Nuclear Medicine

Carbon-11 labeled thymidine (TdR) is being used for brain tumor imaging in patients with PET. Following clearance of 5-methyl C-11 TdR from plasma in humans, there is a progressive increase of C-11 activity in normal brain and tumor presumably secondary to accumulation of C-11 beta-AIB, a major by-product of thymidine catabolism in vivo. Canine studies have demonstrated that the major radiolabeled species in acid soluble extracts of brain and tumor tissues during C-14 TdR studies is beta-AIB. The previously reported synthesis of beta-AIB is not suitable for incorporation of carbon-11. A convenient method of synthesis of C-11 beta-AIB was developedmore »« less

Similar Records